Samenvatting
Cefpirome, a fourth generation cephalosporin, was administered during 154 episodes of febrile neutropenia in 106 patients. We assessed the clinical efficacy of cefpirome and its activity against isolated pathogens in neutropenic patients with hematologic malignancies. In addition, the pharmacokinetics and optimal dosing regimen of cefpirome during neutropenia were investigated.
| Originele taal-2 | Engels |
|---|---|
| Pagina's (van-tot) | 1005-6 |
| Aantal pagina's | 2 |
| Tijdschrift | Haematologica |
| Volume | 90 |
| Nummer van het tijdschrift | 7 |
| Status | Gepubliceerd - jul. 2005 |
| Extern gepubliceerd | Ja |
Vingerafdruk
Duik in de onderzoeksthema's van 'Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies'. Samen vormen ze een unieke vingerafdruk.Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver